A Multiple Injection Study Evaluating Safety and Efficacy of Ampion in Osteoarthritis

Summary

This study will evaluate the efficacy of three intra-articular injections, given 2 weeks apart, of Ampion™ in Adults with pain due to osteoarthritis of the knee.

Timeline

Start

2014-09

Primary completion

2015-04

Completion

2015-05

Outcome

Missed primary endpoint

registry analysis (superiority test); Ampion 4 mL Injection vs Placebo 4 mL Injection; p = 0.26; ANCOVA; note: Adjusted for baseline WOMAC score. NCT02242435 ↗

Drugs

Indications